Clinical Trials Browser

Recurrence × Pharmacokinetics × Clear all

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia